1. Home
  2. ARQT vs SMA Comparison

ARQT vs SMA Comparison

Compare ARQT & SMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARQT
  • SMA
  • Stock Information
  • Founded
  • ARQT 2016
  • SMA 2013
  • Country
  • ARQT United States
  • SMA United States
  • Employees
  • ARQT N/A
  • SMA N/A
  • Industry
  • ARQT Biotechnology: Pharmaceutical Preparations
  • SMA
  • Sector
  • ARQT Health Care
  • SMA
  • Exchange
  • ARQT Nasdaq
  • SMA NYSE
  • Market Cap
  • ARQT 1.6B
  • SMA 1.8B
  • IPO Year
  • ARQT 2020
  • SMA 2025
  • Fundamental
  • Price
  • ARQT $13.52
  • SMA $35.87
  • Analyst Decision
  • ARQT Strong Buy
  • SMA Strong Buy
  • Analyst Count
  • ARQT 6
  • SMA 6
  • Target Price
  • ARQT $18.80
  • SMA $38.00
  • AVG Volume (30 Days)
  • ARQT 2.1M
  • SMA 443.1K
  • Earning Date
  • ARQT 05-06-2025
  • SMA 05-07-2025
  • Dividend Yield
  • ARQT N/A
  • SMA 0.76%
  • EPS Growth
  • ARQT N/A
  • SMA N/A
  • EPS
  • ARQT N/A
  • SMA N/A
  • Revenue
  • ARQT $212,819,000.00
  • SMA $235,972,000.00
  • Revenue This Year
  • ARQT $57.99
  • SMA N/A
  • Revenue Next Year
  • ARQT $41.24
  • SMA N/A
  • P/E Ratio
  • ARQT N/A
  • SMA N/A
  • Revenue Growth
  • ARQT 100.03
  • SMA 5.42
  • 52 Week Low
  • ARQT $6.99
  • SMA $29.89
  • 52 Week High
  • ARQT $17.75
  • SMA $36.41
  • Technical
  • Relative Strength Index (RSI)
  • ARQT 42.59
  • SMA N/A
  • Support Level
  • ARQT $12.42
  • SMA N/A
  • Resistance Level
  • ARQT $15.67
  • SMA N/A
  • Average True Range (ATR)
  • ARQT 0.87
  • SMA 0.00
  • MACD
  • ARQT -0.03
  • SMA 0.00
  • Stochastic Oscillator
  • ARQT 33.69
  • SMA 0.00

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

About SMA SMARTSTOP SELF STORAGE REIT INC

Smartstop Self Storage REIT Inc operates as a real estate investment trust. The trust owns, acquires, and operates self-storage properties. It operates in two segments namely, self-storage operations which generates key revenue, and managed REIT platform business. The investment objective is to focus on investing in self-storage facilities and related self-storage real estate investments that are expected to support sustainable stockholder distributions over the long term.

Share on Social Networks: